Comparison of lamotrigine to placebo in infants 1-24 months of age with partial seizures: Impact of response during open-label enrichment phase

被引：0
|
作者：
Warnock, CR
Caldwell, PT
Messenheimer, JA
机构：
[1] GlaxoSmithKline Inc, Biol Data Sci, Res Triangle Pk, NC USA
[2] GlaxoSmithKline Inc, Neurosci Clin Dev, Res Triangle Pk, NC USA
来源：
EPILEPSIA | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 22 条
  • [21] Impact of Fremanezumab on Migraine-associated Symptoms in Patients With Episodic and Chronic Migraine and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Medications During the Open-label Period of the Phase 3b FOCUS Study
    Mechtler, Laszlo
    Ning, Xiaoping
    Cohen, Joshua M.
    Campos, Verena Ramirez
    Yang, Ronghua
    NEUROLOGY, 2020, 94 (15)
  • [22] Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
    Zakarya, Kunsulu
    Kutumbetov, Lespek
    Orynbayev, Mukhit
    Abduraimov, Yergali
    Sultankulova, Kulyaisan
    Kassenov, Markhabat
    Sarsenbayeva, Gulbanu
    Kulmagambetov, Ilyas
    Davlyatshin, Timur
    Sergeeva, Maria
    Stukova, Marina
    Khairullin, Berik
    ECLINICALMEDICINE, 2021, 39
123